Daebongls.Co.Ltd
Daebongls.Co.,Ltd. engages in the research, development, and production of cosmetics, pharmaceutical raw materials, food and feed products in South Korea and internationally. The company's Cosmetic Ingredients division offers special cosmetic ingredients comprising fresh green tea, black ginseng water, jeju hatban extract, wormwood extract, jeju camellia oil, jeju dang oil extract, jeju basalt po… Read more
Daebongls.Co.Ltd - Asset Resilience Ratio
Daebongls.Co.Ltd (078140) has an Asset Resilience Ratio of 17.35% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2024)
This chart shows how Daebongls.Co.Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Daebongls.Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩44.31 Billion | 17.35% |
| Total Liquid Assets | ₩44.31 Billion | 17.35% |
Asset Resilience Insights
- Good Liquidity Position: Daebongls.Co.Ltd maintains a healthy 17.35% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Daebongls.Co.Ltd Industry Peers by Asset Resilience Ratio
Compare Daebongls.Co.Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
AGP Ltd
KAR:AGP |
Pharmaceuticals | 0.71% |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250 |
Pharmaceuticals | 4.82% |
|
DongKoo Bio&Pharma Co. Ltd
KQ:006620 |
Pharmaceuticals | 4.28% |
|
NatureCell Co.Ltd
KQ:007390 |
Pharmaceuticals | 0.00% |
|
Sam-A Pharm. Co. Ltd
KQ:009300 |
Pharmaceuticals | 34.37% |
|
Kyung Dong Pharmaceutical Co. Ltd
KQ:011040 |
Pharmaceuticals | 5.22% |
|
WooGene B&G Co. Ltd
KQ:018620 |
Pharmaceuticals | 3.35% |
|
Oscotec Inc
KQ:039200 |
Pharmaceuticals | 61.00% |
Annual Asset Resilience Ratio for Daebongls.Co.Ltd (2011–2024)
The table below shows the annual Asset Resilience Ratio data for Daebongls.Co.Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 31.74% | ₩75.76 Billion | ₩238.71 Billion | -5.34pp |
| 2023-12-31 | 37.08% | ₩72.27 Billion | ₩194.92 Billion | -11.38pp |
| 2022-12-31 | 48.46% | ₩90.20 Billion | ₩186.14 Billion | +9.91pp |
| 2021-12-31 | 38.54% | ₩62.92 Billion | ₩163.24 Billion | -8.81pp |
| 2020-12-31 | 47.35% | ₩70.93 Billion | ₩149.79 Billion | +27.34pp |
| 2019-12-31 | 20.02% | ₩20.44 Billion | ₩102.13 Billion | -0.07pp |
| 2018-12-31 | 20.09% | ₩17.46 Billion | ₩86.93 Billion | +1.38pp |
| 2017-12-31 | 18.71% | ₩15.05 Billion | ₩80.45 Billion | +0.44pp |
| 2016-12-31 | 18.27% | ₩13.78 Billion | ₩75.43 Billion | +2.68pp |
| 2015-12-31 | 15.58% | ₩10.20 Billion | ₩65.47 Billion | +3.75pp |
| 2014-12-31 | 11.83% | ₩6.70 Billion | ₩56.65 Billion | +1.19pp |
| 2013-12-31 | 10.64% | ₩5.43 Billion | ₩51.03 Billion | +3.42pp |
| 2012-12-31 | 7.22% | ₩3.36 Billion | ₩46.55 Billion | -6.40pp |
| 2011-12-31 | 13.63% | ₩5.97 Billion | ₩43.84 Billion | -- |